| 摘要 |
The present invention relates to imidazole derivatives which are mGluR5 receptor antagonists and which are represented by the general formula (I): wherein R1, R 2, R3 and R4 are as defined in the specification, to a process for the manufacture thereof, as well as to pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment or prevention of mGluR5 receptor mediated disorders, such as acute and/or chronic neurological disorders.
|
